HomepageMedicineMerck Obtains Global License for Hansoh’s HS-10535 Medicine Merck Obtains Global License for Hansoh’s HS-10535 admin Posted on December 23, 2024 The molecule is an investigational pre-clinical oral GLP-1 receptor agonist. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostAsk Dr. Paola – Monday December 23, 2024 Next PostWill There Ever Be Real Size Diversity in Fashion? You Might Also Like Medicine FDA Approves Incyte and Syndax’s Niktimvo for Chronic Graft-Versus-Host Disease in 9 and 22 mg Vial Sizes admin January 17, 2025 Medicine DELFI Diagnostics Launches Assay That May Improve Monitoring of Cancer Treatment Response admin February 2, 2024 Medicine Pfizer Appoints New Chief Scientific Officer and President, Research and Development admin November 21, 2024 Medicine An Enterprise-Wide Approach to Customer Intelligence admin January 2, 2024
Medicine FDA Approves Incyte and Syndax’s Niktimvo for Chronic Graft-Versus-Host Disease in 9 and 22 mg Vial Sizes admin January 17, 2025
Medicine DELFI Diagnostics Launches Assay That May Improve Monitoring of Cancer Treatment Response admin February 2, 2024
Medicine Pfizer Appoints New Chief Scientific Officer and President, Research and Development admin November 21, 2024